ClinicalTrials.Veeva

Menu

Withholding Feeds During Red Blood Cell Transfusion and TRAGI (Tx-TRAGI)

Z

Zekai Tahir Burak Women's Health Research and Education Hospital

Status and phase

Unknown
Phase 4

Conditions

Feeding During Transfusion
Necrotising Enterocolitis
Transfusion
Transfusion Related Acute Gut Injury

Treatments

Other: Withholding feeds
Other: feeding during transfusion

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Necrotising enterocolitis (NEC) is a devastating picture that all the neonatologists are afraid of facing during the follow up of newborns. During the last years, investigators ran retrospective observational studies abut NEC developing within the 48 hours after red blood cell transfusion. In the previous studies, the incidence of transfusion associated NEC (TANEC) was found to be 20-35%.Multiple transfusions potentially cause an increased risk for retinopathy of prematurity (ROP) and NEC. Investigators have also proposed a hypothesis about transfusion related acute gut injury (TRAGI), an adverse reaction of transfusion, similar to transfusion related acute lung injury (TRALI) seen in adults.In most of the neonatology clinics, withholding feeds during transfusion is not preferred. But several recent studies show an increase in the incidence of TANEC if the newborn goes on feeding before, during and after the transfusion process, especially if it is fed with a formula. The main aim of this study is to investigate the effect of withholding feeds during transfusion, on the development of TRAGI.

Enrollment

150 estimated patients

Sex

All

Ages

7 days to 3 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • <32 weeks of gestational age or <1500 gr, >7 days old premature babies.
  • Babies which are fed enterally well at the time of tha planning of transfusion.

Exclusion criteria

  • Babies with severe sepsis signs.
  • Babies with severe hypoxia and asphyxia.
  • Babies with congenital anomaly or complex cardiac anomaly.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 2 patient groups, including a placebo group

Feeding During Transfusion
Placebo Comparator group
Description:
The feeding process will be continued during the transfusion
Treatment:
Other: feeding during transfusion
witholding feeds
Active Comparator group
Description:
At least 2 feeds before the transfusion, 2 feeds after the transfusion and feeds during the transfusion are withholded
Treatment:
Other: Withholding feeds

Trial contacts and locations

1

Loading...

Central trial contact

Suzan Sahin, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems